Lara Nilton Alves, Teixeira Manoel J, Fonoff Erich T
Division of Neurosurgery, University Of São Paulo, São Paulo, Brazil.
Acta Neurochir Suppl. 2011;108:41-7. doi: 10.1007/978-3-211-99370-5_8.
Failed Back Surgery Syndrome (FBSS) is a multidimensional painful condition and its treatment remains a challenge for the surgeons. Prolonged intrathecal infusion of opiates for treatment of noncancer pain also remains a controversial issue. The authors present a prospective study about the long-term treatment of 30 patients with nonmalignant pain treated with intrathecal infusion of morphine from February, 1996 to May, 2004. Self-administration pumps were implanted in 18 patients and constant-flow pumps in 12. The mean intensity of pain reduced from 9.5 to 4.6 according to the visual analogue scale (p < 0.001); the mean daily dose of morphine necessary for pain control became constant after the sixth month of treatment. No difference was observed in the results between patients treated with bolus or constant infusion. Side effects were more frequent at the beginning and became tolerable after the first month of treatment. There was improvement of the quality of life measured by SF-36 (30.8-49.6) and in all dimensions of the Treatment of Pain Survey, except for working capacity. The follow-up period ranged from 18 to 98 months (mean = 46.7 months). It was concluded that intrathecal infusion of morphine is a useful and safe tool for long-term treatment of chronic nonmalignant pain.
腰椎手术失败综合征(FBSS)是一种多维度的疼痛病症,其治疗对外科医生来说仍然是一项挑战。鞘内长期输注阿片类药物用于治疗非癌性疼痛也仍然是一个有争议的问题。作者开展了一项前瞻性研究,对1996年2月至2004年5月期间接受鞘内注射吗啡治疗的30例非恶性疼痛患者进行长期治疗。18例患者植入了自控镇痛泵,12例患者植入了恒流泵。根据视觉模拟量表,疼痛平均强度从9.5降至4.6(p<0.001);治疗六个月后,控制疼痛所需的吗啡平均日剂量趋于稳定。推注或持续输注治疗的患者结果无差异。副作用在开始时更频繁,治疗第一个月后变得可耐受。通过SF-36(30.8-49.6)测量的生活质量以及疼痛治疗调查的所有维度均有改善,但工作能力除外。随访期为18至98个月(平均=46.7个月)。研究得出结论,鞘内注射吗啡是长期治疗慢性非恶性疼痛的一种有用且安全的方法。